Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery

The therapeutic potential of small nucleic acids such as small interfering RNA (siRNA) to treat lung diseases has been successfully demonstrated in many in vivo studies. A major barrier to their clinical application is the lack of a safe and efficient inhaled formulation. In this study, spray freeze...

Full description

Bibliographic Details
Main Authors: Wanling Liang, Alan Y.L. Chan, Michael Y.T. Chow, Fiona F.K. Lo, Yingshan Qiu, Philip C.L. Kwok, Jenny K.W. Lam
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:Asian Journal of Pharmaceutical Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S1818087617303902
id doaj-7b65090aaf434ec2b46a1a9e1ac43fee
record_format Article
spelling doaj-7b65090aaf434ec2b46a1a9e1ac43fee2020-11-25T00:02:01ZengElsevierAsian Journal of Pharmaceutical Sciences1818-08762018-03-01132163172Spray freeze drying of small nucleic acids as inhaled powder for pulmonary deliveryWanling Liang0Alan Y.L. Chan1Michael Y.T. Chow2Fiona F.K. Lo3Yingshan Qiu4Philip C.L. Kwok5Jenny K.W. Lam6Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong, ChinaDepartment of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong, ChinaDepartment of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong, ChinaDepartment of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong, ChinaDepartment of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong, ChinaDepartment of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong, China; Advanced Drug Delivery Group, Faculty of Pharmacy, The University of Sydney, Building A15, Sydney, NSW 2006, AustraliaDepartment of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong, China; Corresponding author. Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong, China. Tel.: +852 3917 9599;The therapeutic potential of small nucleic acids such as small interfering RNA (siRNA) to treat lung diseases has been successfully demonstrated in many in vivo studies. A major barrier to their clinical application is the lack of a safe and efficient inhaled formulation. In this study, spray freeze drying was employed to prepare dry powder of small nucleic acids. Mannitol and herring sperm DNA were used as bulking agent and model of small nucleic acid therapeutics, respectively. Formulations containing different solute concentration and DNA concentration were produced. The scanning electron microscope (SEM) images showed that the porosity of the particles increased as the solute concentration decreased. Powders prepared with solute concentration of 5% w/v were found to maintain a balance between porosity and robustness. Increasing concentration of DNA improved the aerosol performance of the formulation. The dry powder formulation containing 2% w/w DNA had a median diameter of 12.5 µm, and the aerosol performance study using next generation impactor (NGI) showed an emitted fraction (EF) and fine particle fraction (FPF) of 91% and 28% respectively. This formulation (5% w/v solute concentration and 2% w/w nucleic acid) was adopted subsequently to produce siRNA powder. The gel retardation and liquid chromatography assays showed that the siRNA remained intact after spray freeze drying even in the absence of delivery vector. The siRNA powder formulation exhibited a high EF of 92.4% and a modest FPF of around 20%. Further exploration of this technology to optimise inhaled siRNA powder formulation is warranted. Keywords: Inhalation, Pulmonary delivery, Small interfering RNA, Spray freeze dryinghttp://www.sciencedirect.com/science/article/pii/S1818087617303902
collection DOAJ
language English
format Article
sources DOAJ
author Wanling Liang
Alan Y.L. Chan
Michael Y.T. Chow
Fiona F.K. Lo
Yingshan Qiu
Philip C.L. Kwok
Jenny K.W. Lam
spellingShingle Wanling Liang
Alan Y.L. Chan
Michael Y.T. Chow
Fiona F.K. Lo
Yingshan Qiu
Philip C.L. Kwok
Jenny K.W. Lam
Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery
Asian Journal of Pharmaceutical Sciences
author_facet Wanling Liang
Alan Y.L. Chan
Michael Y.T. Chow
Fiona F.K. Lo
Yingshan Qiu
Philip C.L. Kwok
Jenny K.W. Lam
author_sort Wanling Liang
title Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery
title_short Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery
title_full Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery
title_fullStr Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery
title_full_unstemmed Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery
title_sort spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery
publisher Elsevier
series Asian Journal of Pharmaceutical Sciences
issn 1818-0876
publishDate 2018-03-01
description The therapeutic potential of small nucleic acids such as small interfering RNA (siRNA) to treat lung diseases has been successfully demonstrated in many in vivo studies. A major barrier to their clinical application is the lack of a safe and efficient inhaled formulation. In this study, spray freeze drying was employed to prepare dry powder of small nucleic acids. Mannitol and herring sperm DNA were used as bulking agent and model of small nucleic acid therapeutics, respectively. Formulations containing different solute concentration and DNA concentration were produced. The scanning electron microscope (SEM) images showed that the porosity of the particles increased as the solute concentration decreased. Powders prepared with solute concentration of 5% w/v were found to maintain a balance between porosity and robustness. Increasing concentration of DNA improved the aerosol performance of the formulation. The dry powder formulation containing 2% w/w DNA had a median diameter of 12.5 µm, and the aerosol performance study using next generation impactor (NGI) showed an emitted fraction (EF) and fine particle fraction (FPF) of 91% and 28% respectively. This formulation (5% w/v solute concentration and 2% w/w nucleic acid) was adopted subsequently to produce siRNA powder. The gel retardation and liquid chromatography assays showed that the siRNA remained intact after spray freeze drying even in the absence of delivery vector. The siRNA powder formulation exhibited a high EF of 92.4% and a modest FPF of around 20%. Further exploration of this technology to optimise inhaled siRNA powder formulation is warranted. Keywords: Inhalation, Pulmonary delivery, Small interfering RNA, Spray freeze drying
url http://www.sciencedirect.com/science/article/pii/S1818087617303902
work_keys_str_mv AT wanlingliang sprayfreezedryingofsmallnucleicacidsasinhaledpowderforpulmonarydelivery
AT alanylchan sprayfreezedryingofsmallnucleicacidsasinhaledpowderforpulmonarydelivery
AT michaelytchow sprayfreezedryingofsmallnucleicacidsasinhaledpowderforpulmonarydelivery
AT fionafklo sprayfreezedryingofsmallnucleicacidsasinhaledpowderforpulmonarydelivery
AT yingshanqiu sprayfreezedryingofsmallnucleicacidsasinhaledpowderforpulmonarydelivery
AT philipclkwok sprayfreezedryingofsmallnucleicacidsasinhaledpowderforpulmonarydelivery
AT jennykwlam sprayfreezedryingofsmallnucleicacidsasinhaledpowderforpulmonarydelivery
_version_ 1725439985295818752